156 related articles for article (PubMed ID: 36870954)
1. YTHDF2 exerts tumor-suppressor roles in gastric cancer via up-regulating PPP2CA independently of m
Zhou Y; Fan K; Dou N; Li L; Wang J; Chen J; Li Y; Gao Y
Biol Proced Online; 2023 Mar; 25(1):6. PubMed ID: 36870954
[TBL] [Abstract][Full Text] [Related]
2. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
3. YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance.
Yang J; Chen Y; He Y; Da M
Drug Dev Res; 2024 Apr; 85(2):e22179. PubMed ID: 38616512
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.
Shen X; Zhao K; Xu L; Cheng G; Zhu J; Gan L; Wu Y; Zhuang Z
Front Genet; 2020; 11():592042. PubMed ID: 33505426
[TBL] [Abstract][Full Text] [Related]
5. PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.
Sun S; Liu Y; Zhou M; Wen J; Xue L; Han S; Liang J; Wang Y; Wei Y; Yu J; Long X; Chen X; Liang H; Huang Z; Zhang B
Cell Biosci; 2022 May; 12(1):55. PubMed ID: 35526051
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.
Yang H; Hu Y; Weng M; Liu X; Wan P; Hu Y; Ma M; Zhang Y; Xia H; Lv K
J Adv Res; 2022 Mar; 37():91-106. PubMed ID: 35499052
[TBL] [Abstract][Full Text] [Related]
7. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
8. FBW7 suppresses ovarian cancer development by targeting the N
Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
Liu R; Jia Y; Kong G; He A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107
[TBL] [Abstract][Full Text] [Related]
10. The biological function of m6A reader YTHDF2 and its role in human disease.
Wang JY; Lu AQ
Cancer Cell Int; 2021 Feb; 21(1):109. PubMed ID: 33593354
[TBL] [Abstract][Full Text] [Related]
11. N
Zhang Z; Xing Y; Gao W; Yang L; Shi J; Song W; Li T
Bioengineered; 2022 May; 13(5):11541-11550. PubMed ID: 35502827
[TBL] [Abstract][Full Text] [Related]
12. Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism.
Chen X; Lu T; Ding M; Cai Y; Yu Z; Zhou X; Wang X
J Adv Res; 2023 Oct; ():. PubMed ID: 37865189
[TBL] [Abstract][Full Text] [Related]
13. m
Chen X; Zhou X; Wang X
Exp Hematol Oncol; 2022 Apr; 11(1):21. PubMed ID: 35382893
[TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation.
Xu J; Shang Y; Qin X; Gai Y; Cai F; Xiao H; Zhou C; Fu Y; Ge X
Contrast Media Mol Imaging; 2022; 2022():1087622. PubMed ID: 35924072
[TBL] [Abstract][Full Text] [Related]
15. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
16. The m
Chen XY; Liang R; Yi YC; Fan HN; Chen M; Zhang J; Zhu JS
Front Cell Dev Biol; 2021; 9():647702. PubMed ID: 33791305
[TBL] [Abstract][Full Text] [Related]
17. m
Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
19. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker.
Liu W; Liu C; You J; Chen Z; Qian C; Lin W; Yu L; Ye L; Zhao L; Zhou R
Front Cell Dev Biol; 2022; 10():954214. PubMed ID: 36120577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
